These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12161155)

  • 1. 1-(Bicyclopiperazinyl)ethylindoles and 1-(homopiperazinyl)ethyl-indoles as highly selective and potent 5-HT(7) receptor ligands.
    Isaac MB; Xin T; O'Brien A; St-Martin D; Naismith A; MacLean N; Wilson J; Demchyshyn L; Tehim A; Slassi A
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2451-4. PubMed ID: 12161155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-Bicyclopiperazinyl-1-arylsulfonylindoles and 6-bicyclopiperidinyl-1-arylsulfonylindoles derivatives as novel, potent, and selective 5-HT6 receptor antagonists.
    Isaac M; Slassi A; Xin T; MacLean N; Wilson J; McCallum K; Wang H; Demchyshyn L
    Bioorg Med Chem Lett; 2000 Aug; 10(15):1719-21. PubMed ID: 10937732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists.
    Cole DC; Ellingboe JW; Lennox WJ; Mazandarani H; Smith DL; Stock JR; Zhang G; Zhou P; Schechter LE
    Bioorg Med Chem Lett; 2005 Jan; 15(2):379-83. PubMed ID: 15603958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and preliminary screening of novel 3-(2-N,N-dimethylaminoethylthio) indole derivatives as potential 5-HT(6) receptor ligands.
    Kambhampati R; Konda J; Reballi V; Shinde AK; Dubey PK; Nirogi RV
    J Enzyme Inhib Med Chem; 2008 Jun; 23(3):302-12. PubMed ID: 18569332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective, centrally acting serotonin 5-HT2 antagonists. 2. Substituted 3-(4-fluorophenyl)-1H-indoles.
    Andersen K; Perregaard J; Arnt J; Nielsen JB; Begtrup M
    J Med Chem; 1992 Dec; 35(26):4823-31. PubMed ID: 1336054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and serotonergic activity of substituted 2, N-benzylcarboxamido-5-(2-ethyl-1-dioxoimidazolidinyl)-N, N-dimethyltryptamine derivatives: novel antagonists for the vascular 5-HT(1B)-like receptor.
    Moloney GP; Martin GR; Mathews N; Milne A; Hobbs H; Dodsworth S; Sang PY; Knight C; Williams M; Maxwell M; Glen RC
    J Med Chem; 1999 Jul; 42(14):2504-26. PubMed ID: 10411472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-(Arylsulfonyl)-1-(azacyclyl)-1H-indoles are 5-HT(6) receptor modulators.
    Bernotas RC; Antane S; Shenoy R; Le VD; Chen P; Harrison BL; Robichaud AJ; Zhang GM; Smith D; Schechter LE
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1657-60. PubMed ID: 20138763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New tetrahydrobenzindoles as potent and selective 5-HT(7) antagonists with increased In vitro metabolic stability.
    Kikuchi C; Suzuki H; Hiranuma T; Koyama M
    Bioorg Med Chem Lett; 2003 Jan; 13(1):61-4. PubMed ID: 12467617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New 1-arylindoles based serotonin 5-HT7 antagonists. Synthesis and binding evaluation studies.
    Sagnes C; Fournet G; Satala G; Bojarski AJ; Joseph B
    Eur J Med Chem; 2014 Mar; 75():159-68. PubMed ID: 24531229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicinal chemistry driven approaches toward novel and selective serotonin 5-HT6 receptor ligands.
    Holenz J; Mercè R; Díaz JL; Guitart X; Codony X; Dordal A; Romero G; Torrens A; Mas J; Andaluz B; Hernández S; Monroy X; Sánchez E; Hernández E; Pérez R; Cubí R; Sanfeliu O; Buschmann H
    J Med Chem; 2005 Mar; 48(6):1781-95. PubMed ID: 15771424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of 5-HT(2A) and 5-HT(2C) receptor binding affinities of novel pyrimidine derivatives.
    Bózsing D; Simonek I; Simig G; Jakóczi I; Gacsályi I; Lévay G; Tihanyi K; Schmidt E
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3097-9. PubMed ID: 12372510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azabicyclic indole esters as potent 5-HT4 receptor antagonists.
    Wyman PA; Gaster LM; King FD; Sutton JM; Ellis ES; Wardle KA; Young TJ
    Bioorg Med Chem; 1996 Feb; 4(2):255-61. PubMed ID: 8814883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective, centrally acting serotonin 5-HT2 antagonists. 1. 2- and 6-substituted 1-phenyl-3-(4-piperidinyl)-1H-indoles.
    Perregaard J; Andersen K; Hyttel J; Sánchez C
    J Med Chem; 1992 Dec; 35(26):4813-22. PubMed ID: 1336053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the terminal amide fragment geometry in some 3-arylideneindolin-2(1H)-ones on their 5-HT1A/5-HT2A receptor activity.
    Mokrosz MJ; Charakchieva-Minol S; Kozioł A; Kłodzińska A; Chojnacka-Wójcik E
    Bioorg Med Chem Lett; 2001 May; 11(9):1229-31. PubMed ID: 11354383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-(4-Piperidinyl)- and 3-(8-aza-bicyclo[3.2.1]oct-3-yl)-2-phenyl-1H-indoles as bioavailable h5-HT2A antagonists.
    Crawforth J; Goodacre S; Maxey R; Bourrain S; Patel S; Marwood R; O'Connor D; Herbert R; Hutson P; Rowley M
    Bioorg Med Chem Lett; 2000 Dec; 10(24):2701-3. PubMed ID: 11133072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-[(1-butyl-4-piperidinyl)methyl]-3,4dihydro-2H-[1,3]oxazino[3,2- a]indole10-carboxamide hydrochloride: the first potent and selective 5-HT4 receptor antagonist amide with oral activity.
    Gaster LM; Joiner GF; King FD; Wyman PA; Sutton JM; Bingham S; Ellis ES; Sanger GJ; Wardle KA
    J Med Chem; 1995 Nov; 38(24):4760-3. PubMed ID: 7490724
    [No Abstract]   [Full Text] [Related]  

  • 17. Extended N-Arylsulfonylindoles as 5-HT₆ Receptor Antagonists: Design, Synthesis & Biological Evaluation.
    Vera G; Lagos CF; Almendras S; Hebel D; Flores F; Valle-Corvalán G; Pessoa-Mahana CD; Mella-Raipán J; Montecinos R; Recabarren-Gajardo G
    Molecules; 2016 Aug; 21(8):. PubMed ID: 27537868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncataleptogenic, centrally acting dopamine D-2 and serotonin 5-HT2 antagonists within a series of 3-substituted 1-(4-fluorophenyl)-1H-indoles.
    Perregaard J; Arnt J; Bøgesø KP; Hyttel J; Sánchez C
    J Med Chem; 1992 Mar; 35(6):1092-101. PubMed ID: 1348090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 5-hydroxytryptamine (5-HT3) receptor antagonists. Synthesis and structure-activity relationships of 9-methyl-2,3,4,9-tetrahydrothiopyrano[2,3-b]indol-4-one derivatives.
    Suzuki T; Matsuhisa A; Miyata K; Yanagisawa I; Ohta M
    Chem Pharm Bull (Tokyo); 1997 Jan; 45(1):101-6. PubMed ID: 9023971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT(2A) receptor antagonists.
    Rowley M; Hallett DJ; Goodacre S; Moyes C; Crawforth J; Sparey TJ; Patel S; Marwood R; Patel S; Thomas S; Hitzel L; O'Connor D; Szeto N; Castro JL; Hutson PH; MacLeod AM
    J Med Chem; 2001 May; 44(10):1603-14. PubMed ID: 11334570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.